Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Imipenem and Cilastatin Sodium market size was valued at USD 648.97 million in 2022 and is expected to expand at a CAGR of 4.15% during the forecast period, reaching USD 828.15 million by 2028.
A bactericidal drug, imipenem inhibits bacterial cell wall synthesis. Its spectrum of antimicrobial activity includes many gram-positive, gram-negative, and anaerobic bacteria, including Escherichia coli; Pseudomonas aeruginosa; Bacteroides species, including B. fragilis; and Staphylococcus, Streptococcus, Klebsiella, Proteus, and Enterobacter species. Resistant bacteria include methicillin-resistant staphylococci, Clostridium difficile, and other Pseudomonas species. Cilastatin inhibits the enzymatic breakdown of imipenem in the kidneys, making it effective in treating urinary tract infections.
COVID-19's impact on the Imipenem and Cilastatin Sodium industry
In the specific environment based on the outbreak of COVID-19, the global economy has been significantly affected, resulting in challenges and opportunities for the development status of various industries. The report is based on the impact of COVID-19 and conducts research on the Imipenem and Cilastatin Sodium industry from different perspectives such as macroeconomics, industrial chains, and regions.
Market Restraints Analysis
The fierce competition in the imipenem and cilastatin sodium market is inevitable. Established companies that have not yet entered the field of preparations have more ideas to wait and see or consider entering the field of preparations. Some intermediate and raw material manufacturers have plans to expand their production capacity. The price fight is still going on. Therefore, this variety, especially in intermediate products, will experience a process of competition and gradual integration.
Quality and technology are the key. At present, there are still technical thresholds for imipenem and cilastatin sodium. At present, Merck Pharmaceuticals has a first-mover advantage that is several years ahead. International purchasing manufacturers have also adapted to use Merck's mature technology and stable quality products. The products with lower quality are mainly supplied to buyers with low quality requirements at lower prices. In view of the relatively small scale of demand for imipenem and cilastatin sodium, companies should consider relying on high added value to obtain profits, objectively they must obtain profits through reasonable prices, rather than scale. Blindly expanding the scale is definitely not a wise choice. If the quality cannot keep up, it will ultimately fail to win the market.
Region Overview:
From 2023-2028, Asia Pacific is estimated to witness robust growth prospects.
Company Overview:
Merck is one of the major players operating in the Imipenem and Cilastatin Sodium market, holding a share of 58% in 2020.
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.
Pfizer is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines.
Segmentation Overview:
Among different product types, 500mg segment is anticipated to contribute the largest market share in 2028.
Application Overview:
By application, the Hospital segment occupied the biggest share from 2018 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Imipenem and Cilastatin Sodium industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Imipenem and Cilastatin Sodium. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Imipenem and Cilastatin Sodium Market Report Include:
Market Size Estimates: Imipenem and Cilastatin Sodium market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Imipenem and Cilastatin Sodium market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Imipenem and Cilastatin Sodium market
Segment Market Analysis: Imipenem and Cilastatin Sodium market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Imipenem and Cilastatin Sodium market situations and prospects in major and top regions and countries
Imipenem and Cilastatin Sodium Market
Imipenem and Cilastatin Sodium Industry Chain: Imipenem and Cilastatin Sodium market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Imipenem and Cilastatin Sodium Industry News, Policies by regions
Imipenem and Cilastatin Sodium Industry Porters Five Forces Analysis
Key players in the global Imipenem and Cilastatin Sodium market are covered in Chapter 2:
Zhejiang Hisun
Pfizer
Merck
Savior Lifetec Corporation
Shenzhen Haibin Pharmaceutical
In Chapter 6 and Chapter 9, on the basis of types, the Imipenem and Cilastatin Sodium market from 2018 to 2028 is primarily split into:
250mg
500mg
In Chapter 7 and Chapter 10, on the basis of applications, the Imipenem and Cilastatin Sodium market from 2018 to 2028 covers:
Hospital
Laboratory
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Imipenem and Cilastatin Sodium market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Imipenem and Cilastatin Sodium industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Imipenem and Cilastatin Sodium market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Imipenem and Cilastatin Sodium industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Imipenem and Cilastatin Sodium market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Imipenem and Cilastatin Sodium market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Imipenem and Cilastatin Sodium market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
A bactericidal drug, imipenem inhibits bacterial cell wall synthesis. Its spectrum of antimicrobial activity includes many gram-positive, gram-negative, and anaerobic bacteria, including Escherichia coli; Pseudomonas aeruginosa; Bacteroides species, including B. fragilis; and Staphylococcus, Streptococcus, Klebsiella, Proteus, and Enterobacter species. Resistant bacteria include methicillin-resistant staphylococci, Clostridium difficile, and other Pseudomonas species. Cilastatin inhibits the enzymatic breakdown of imipenem in the kidneys, making it effective in treating urinary tract infections.
COVID-19's impact on the Imipenem and Cilastatin Sodium industry
In the specific environment based on the outbreak of COVID-19, the global economy has been significantly affected, resulting in challenges and opportunities for the development status of various industries. The report is based on the impact of COVID-19 and conducts research on the Imipenem and Cilastatin Sodium industry from different perspectives such as macroeconomics, industrial chains, and regions.
Market Restraints Analysis
The fierce competition in the imipenem and cilastatin sodium market is inevitable. Established companies that have not yet entered the field of preparations have more ideas to wait and see or consider entering the field of preparations. Some intermediate and raw material manufacturers have plans to expand their production capacity. The price fight is still going on. Therefore, this variety, especially in intermediate products, will experience a process of competition and gradual integration.
Quality and technology are the key. At present, there are still technical thresholds for imipenem and cilastatin sodium. At present, Merck Pharmaceuticals has a first-mover advantage that is several years ahead. International purchasing manufacturers have also adapted to use Merck's mature technology and stable quality products. The products with lower quality are mainly supplied to buyers with low quality requirements at lower prices. In view of the relatively small scale of demand for imipenem and cilastatin sodium, companies should consider relying on high added value to obtain profits, objectively they must obtain profits through reasonable prices, rather than scale. Blindly expanding the scale is definitely not a wise choice. If the quality cannot keep up, it will ultimately fail to win the market.
Region Overview:
From 2023-2028, Asia Pacific is estimated to witness robust growth prospects.
Company Overview:
Merck is one of the major players operating in the Imipenem and Cilastatin Sodium market, holding a share of 58% in 2020.
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.
Pfizer is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines.
Segmentation Overview:
Among different product types, 500mg segment is anticipated to contribute the largest market share in 2028.
Application Overview:
By application, the Hospital segment occupied the biggest share from 2018 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Imipenem and Cilastatin Sodium industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Imipenem and Cilastatin Sodium. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Imipenem and Cilastatin Sodium Market Report Include:
Market Size Estimates: Imipenem and Cilastatin Sodium market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Imipenem and Cilastatin Sodium market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Imipenem and Cilastatin Sodium market
Segment Market Analysis: Imipenem and Cilastatin Sodium market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Imipenem and Cilastatin Sodium market situations and prospects in major and top regions and countries
Imipenem and Cilastatin Sodium Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Imipenem and Cilastatin Sodium Industry Chain: Imipenem and Cilastatin Sodium market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Imipenem and Cilastatin Sodium Industry News, Policies by regions
Imipenem and Cilastatin Sodium Industry Porters Five Forces Analysis
Key players in the global Imipenem and Cilastatin Sodium market are covered in Chapter 2:
Zhejiang Hisun
Pfizer
Merck
Savior Lifetec Corporation
Shenzhen Haibin Pharmaceutical
In Chapter 6 and Chapter 9, on the basis of types, the Imipenem and Cilastatin Sodium market from 2018 to 2028 is primarily split into:
250mg
500mg
In Chapter 7 and Chapter 10, on the basis of applications, the Imipenem and Cilastatin Sodium market from 2018 to 2028 covers:
Hospital
Laboratory
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Imipenem and Cilastatin Sodium market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Imipenem and Cilastatin Sodium industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Imipenem and Cilastatin Sodium market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Imipenem and Cilastatin Sodium industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Imipenem and Cilastatin Sodium market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Imipenem and Cilastatin Sodium market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Imipenem and Cilastatin Sodium market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
